Daily 1
99/100
This product looks safe
- Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
- 67% of ingredients have research evidence
C
Label Compliance Grade
What the Evidence Says
AI-generated · Qwen 3.6 · methodologyThis formula contains Nicotinamide Riboside and BioPQQ, which are studied for cellular energy and mitochondrial support. It also includes vitamins A, C, and D3, which have strong evidence for supporting immune function and overall health. Research on the synergistic effects of these specific combined ingredients remains limited.
AI-generated summary based on research evidence. Not medical advice.
Alerts
Safety Alerts
Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
Label
Product Label
Details
Label Data
1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients
Supplement Facts — Evidence Check
BioPQQ
5 mg
Within RDA (0.7× RDA)
196 studies (A:5, B:63)
Vitamin A
1000 mcg
(125% DV)
Vitamin C
470 mg
(587% DV)
50 mcg
(1000% DV)
3.3× RDA — above typical dose (UL: 0.1 mg)
608 studies (A:16, B:251)
80 mg
(665% DV)
5.3× RDA — above typical dose (UL: 1000 mg)
179 studies (A:3, B:90)
75 mg
(6800% DV)
62.5× RDA — above typical dose
76 studies (A:0, B:33)
50 mg
(3570% DV)
38.5× RDA — above typical dose
13 studies (A:0, B:1)
50 mg
(310% DV)
Exceeds UL by 1.4× (UL: 35 mg)
196 studies (A:5, B:63)
50 mg
(830% DV)
10.0× RDA — above typical dose
2 studies — no high-quality reviews
12.5 mg
(890% DV)
9.6× RDA — above typical dose (UL: 100 mg)
114 studies (A:3, B:35)
500 mcg
(250% DV)
1.2× RDA — within safe limits
226 studies (A:10, B:105)
400 mcg
(16000% DV)
166.7× RDA — above typical dose
139 studies (A:1, B:44)
50 mg
Market median: 550.0mg (217 products)
29 studies (A:0, B:5)
300 mcg
(600% DV)
10.0× RDA — above typical dose
27 studies (A:0, B:11)
3 mg
Market median: 3.0mg (58 products)
3 studies — no high-quality reviews
200 mcg
(500% DV)
5.7× RDA — above typical dose
199 studies (A:1, B:55)
150 mcg
(100% DV)
Within RDA (1.0× RDA)
245 studies (A:4, B:133)
100 mg
(26% DV)
Within RDA (0.2× RDA)
316 studies (A:8, B:159)
2 mg
(100% DV)
Within RDA (0.9× RDA)
9 studies — no high-quality reviews
100 mcg
(200% DV)
2.2× RDA — within safe limits
3 studies — no high-quality reviews
150 mcg
(270% DV)
2.7× RDA — within safe limits
173 studies (A:0, B:67)
15 mg
(150% DV)
1.4× RDA — within safe limits
263 studies (A:6, B:134)
30 mg
Market median: 200.0mg (198 products)
6 studies — no high-quality reviews
15 mg
Market median: 500.0mg (283 products)
174 studies (A:0, B:62)
11 mg
Market median: 10.0mg (105 products)
2 studies (A:0, B:1)
10 mg
Market median: 100.0mg (283 products)
144 studies (A:1, B:64)
Apigenin
5 mg
2 mg
Market median: 4.0mg (47 products)
1 mg
Market median: 10.0mg (35 products)
6 studies (A:0, B:2)
Other Ingredients
Calcium Carbonate
Stearic Acid
Maltodextrin
Croscarmellose Sodium
HPMC
Claims
Label Claims — Verification
Unverified
All Other
Info
Product Information
Directions for Use
Take 1 tablet daily with a meal.
Warnings & Precautions
Precautions: Contains iodine and a soy derivative.
Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used to replace a varied, balanced diet or healthy lifestyle. As with any dietary supplement, consult a healthcare professional before consuming if you have a health condition.
Directions: For adults only. Keep out of young children's reach.
Not recommended for pregnant or breastfeeding women.
Formulation Notes
BioPQQ, Mitsubishi, Japan
Metadata
Product Details
UPC / SKU5 453003 828068
DSLD Entry Date2025-09-25
Product TypeOther Combinations
FormTablet or Pill
BrandSuperSmart
DSLD ID339823
Data Updated2026-04-11
Research
Research Evidence
10
Research Sources
49
Avg Quality
8
Rct
1
Systematic Review
1
Clinical Trial
B
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
C
The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
C
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
C
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
C
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
C
Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
C
Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
C
Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Clinical Trial
ClinicalTrials.gov
2021
C
A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.
Nicotinamide Riboside research
Best Nicotinamide Riboside
All Nicotinamide Riboside products
More from SuperSmart
View on NIH DSLD →
This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.